The ACAN gene provides instructions for aggrecan, a key building block of cartilage that helps growing bones lengthen and joints absorb pressure. If this gene does not work properly, a person may have short stature, early joint wear, back pain, or a condition affecting bone growth. This gene plays an important role in keeping growth plates and joint cartilage strong and springy. ACAN is mainly known in medicine rather than popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes throughout the body. Some genes provide the information needed to produce proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can read more in LearnHub.
Overview
ACANGene function
What if the gene works
The ACAN gene helps make aggrecan, a major part of cartilage. This lets cartilage hold water, cushion joints, and support normal bone growth, especially in growth plates and the spine.
Risk
What if the gene does not work
Variants in the ACAN gene can cause short stature and changes in bone growth, sometimes with advanced bone age, early joint wear, or disc problems. Milder or more severe variants can shape when features appear and how marked they are.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the ACAN gene does not currently point to a specific medication or a guideline-based ACAN-targeted treatment plan.
Conditions associated with ACAN
Gene function
What if the gene works
Your cartilage needs the ACAN gene to stay springy and supportive. It helps your body make aggrecan, a large protein that gives cartilage its gel-like feel. Understanding the ACAN gene’s role in cartilage and growth plates helps explain how joints, the spine, and growing bones stay supported in daily life.
The ACAN gene helps create the gel-like framework that fills much of cartilage. This framework gives cartilage shape and helps it stay smooth and resilient.
Aggrecan made from the ACAN gene attracts and holds large amounts of water inside cartilage. This keeps the tissue hydrated so it can spring back after everyday pressure.
When you walk, bend, or jump, aggrecan helps cartilage spread and absorb force. This cushioning supports joint surfaces and the discs between the bones of the spine.
In children and teens, the ACAN gene supports the cartilage zones at the ends of growing bones. A strong, organized matrix in these growth plates helps guide steady bone lengthening.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ACAN gene can leave the aggrecan protein shortened, unstable, or reduced, weakening cartilage and its ability to hold water. The way variants in the ACAN gene affect cartilage protein function often falls on a spectrum, with milder variants causing partial loss of activity and more disruptive variants causing a larger loss. Greater functional loss may be linked to earlier growth effects and broader skeletal findings in people with short stature due to variants in the ACAN gene.
How variants are linked to conditions
Pathogenic variants in the ACAN gene can cause proportionate short stature, sometimes with advanced bone age, early osteoarthritis, or osteochondritis dissecans. More disruptive variants can also lead to skeletal conditions such as spondyloepimetaphyseal dysplasia, aggrecan type, and spondyloepiphyseal dysplasia, Kimberley type. This means ACAN gene variants linked to short stature may also matter when joint problems run in a family.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant tied to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ACAN, the main risk comes from having a disease-causing variant, often inherited in a family, and the exact change in the gene can affect how strongly it shows up. Things like higher body weight and heavy joint strain may add to later joint pain or early arthritis, but they do not remove the underlying genetic risk.
Inheritance of ACAN variants
How ACAN gene variants are inherited depends on the specific ACAN-related condition. Many better-known ACAN-related growth and skeletal conditions follow an autosomal dominant pattern, which means a parent carrying the variant can pass it to a child. Some rarer ACAN-related skeletal conditions follow an autosomal recessive pattern, which means a child inherits one ACAN gene variant from each parent. This is why how ACAN variants are inherited can differ across families.
What does my ACAN result mean for my family?
For many ACAN results tied to short stature or early joint problems, the pattern is often dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same result. Family members who seem shorter than expected, had early growth plate changes, or developed joint wear at a young age may be the most likely to share it. In some families, the change starts new in one person, so a parent may not have it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ACAN gene, clinicians use genetic testing with a blood or saliva sample. ACAN genetic testing reads the gene's DNA code to look for variants that may help explain short stature or related bone growth findings. Results are interpreted alongside a person's symptoms and family history.
When should I consider getting a genetic test?
Consider genetic testing for the ACAN gene if there is unexplained short stature in you or your child, especially when several relatives are also shorter than expected. Testing can also be useful when short stature comes with early joint wear, back disc problems, or bone age that seems ahead of age.
A genetic result is only one part of your health story
Genetic results can be informative, but what they can tell you varies depending on the condition and the specific type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how a person responds to medicines. Part of this comes from inherited differences in how the body absorbs, breaks down, and clears a drug, or how strongly the drug acts on its target. Because these differences are common, the same treatment may work better for some people, have less effect in others, or cause more side effects at usual doses.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and personalized treatment decisions. You can explore this topic further in the LearnHub.
Drugs influenced by the ACAN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. General questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Across cultures and time periods, inherited patterns of short stature and early joint problems were noted long before the ACAN gene was identified. In the late 20th century, researchers studying cartilage gradually recognized aggrecan as a major component of growing bones and joints. Building on this early work, scientists mapped the ACAN gene and clarified its place in skeletal growth. In the 1990s and 2000s, families with inherited short stature and related bone findings helped connect ACAN variants to human health. Over time, descriptions became more precise as genetic testing linked this gene to a wider range of growth patterns, from isolated short stature to broader skeletal conditions. These historical steps shaped today’s understanding of ACAN in growth medicine.